Bone marrow niche adaptation, leukemic stem cell persistence, and therapeutic resistance in FLT3 -mutated leukemia
World Journal of Stem Cells · 26.07.2026 · 18 (7)
DOI: 10.4252/wjsc.119893 ↗Kurz gefasst
Fachartikel in der Zeitschrift World Journal of Stem Cells, online erschienen am 26.07.2026. Verfasst von Huai-Bin Zhang und 3 weiteren Autor:innen. Die Arbeit nennt 67 Literaturangaben.
Abstract (Originalsprache)
FLT3 mutations, especially FLT3-internal tandem duplication and FLT3-tyrosine kinase domain mutations, are among the most common genetic lesions in acute myeloid leukemia (AML) and are closely associated with aggressive disease biology, early relapse, and poor survival. Although FLT3 inhibitors have improved outcomes in both newly diagnosed and relapsed/refractory AML, durable remission remains limited by adaptive resistance and the persistence of leukemia stem cells. Increasing evidence indicates that treatment failure in FLT3 -mutated AML is not determined solely by secondary kinase mutations, but also by dynamic interactions between leukemic cells and the bone marrow microenvironment (BMM). The BMM provides structural support, soluble mediators, metabolic substrates, and immune protection, thereby preserving a therapy-tolerant leukemic reservoir. This review summarizes the molecular features of FLT3 mutations, the bidirectional crosstalk between FLT3 -mutated leukemia cells and the BMM, the formation of leukemia stem cell-supportive niches, and the principal mechanisms of microenvironment-mediated resistance, including adhesion signaling, chemokine retention, bypass pathway activation, autophagy, metabolic adaptation, and immune evasion. It also discusses emerging combination strategies aimed at cotargeting FLT3 signaling, the supportive niche, and stem-cell-specific vulnerabilities.
Zitieren
APA
Zhang, H., Jiang, H., Deng, J., & Zhang, N. (2026). Bone marrow niche adaptation, leukemic stem cell persistence, and therapeutic resistance in FLT3 -mutated leukemia. World Journal of Stem Cells, 18(7). https://doi.org/10.4252/wjsc.119893
Vancouver
Zhang H, Jiang H, Deng J, Zhang N. Bone marrow niche adaptation, leukemic stem cell persistence, and therapeutic resistance in FLT3 -mutated leukemia. World Journal of Stem Cells. 2026;18(7). doi:10.4252/wjsc.119893
BibTeX
@article{Zhang2026,
author = {Zhang, Huai-Bin and Jiang, Hui-Hui and Deng, Jian-Chuan and Zhang, Nan},
title = {Bone marrow niche adaptation, leukemic stem cell persistence, and therapeutic resistance in FLT3 -mutated leukemia},
journal = {World Journal of Stem Cells},
year = {2026},
volume = {18},
number = {7},
doi = {10.4252/wjsc.119893}
}
EUVIMED